You've been growing the same strain for three cycles. The first harvest hit like a freight train — calm, euphoric, deeply sedating. By the third, you're smoking twice as much and wondering what changed. You assume it's THC tolerance. But what if the compound that stopped working wasn't THC at all?
Terpene tolerance cannabis research is still in its infancy, yet the question is one of the most practically important ones a long-term grower or medical user can ask. THC tolerance is well-documented — CB1 receptor downregulation is the culprit, and most experienced consumers know the solution. But terpene adaptation? That's a conversation the cannabis content space has almost entirely ignored.
This guide digs into the science of how terpene-driven effects — myrcene's sedation, limonene's mood lift, caryophyllene's anti-anxiety action — interact with receptor systems that may or may not behave like the endocannabinoid system. The answer has direct implications for how you select seeds, rotate strains, and structure a tolerance break.
How THC Tolerance Works: A Brief Recap
THC tolerance is one of the most studied forms of drug tolerance in neuroscience. The mechanism is well-established: repeated THC exposure triggers CB1 receptor downregulation — your brain physically reduces the number of available binding sites and internalizes existing receptors to reduce sensitivity.
Research published in Biological Psychiatry showed that heavy daily cannabis users had CB1 receptor availability reduced by up to 20% compared to non-users, with the most significant reductions in the prefrontal cortex and anterior cingulate. Crucially, those same studies showed that receptor density largely recovered after 28 days of abstinence — the neurological basis for the classic "tolerance break."
THC tolerance is driven by CB1 receptor downregulation — a quantifiable, reversible neurological change. Understanding this mechanism is the baseline for asking whether terpene pathways behave the same way.
The critical point is that CB1 downregulation is receptor-specific. It happens because THC repeatedly binds to and activates CB1 receptors, triggering a predictable cellular response: the receptor gets tagged for internalization, reducing signal strength. The question this article asks is whether terpenes — which act through entirely different receptor systems — trigger the same kind of adaptive response.
For a deeper look at how the endocannabinoid system governs these processes, see our guide on the endocannabinoid system and cannabis chemistry.
How Terpene Effects Work: Different Mechanisms, Different Rules
Terpenes don't produce effects through a single receptor system the way THC does. Instead, they operate across multiple distinct biological pathways — olfactory, GABAergic, serotonergic, and direct cannabinoid receptor modulation — which means the tolerance question is genuinely more complex.
Understanding these pathways individually is the only way to evaluate whether terpene tolerance is likely, possible, or mostly mythological. Here's what the science actually shows for each major pathway.
The Olfactory Pathway: Smell as a Delivery Mechanism
A significant portion of terpene effects — particularly mood elevation from limonene and calming effects from linalool — are mediated through the olfactory system. When you inhale cannabis, aromatic terpene molecules bind to olfactory receptors in the nasal epithelium, triggering neural signals that travel directly to the limbic system, including the amygdala and hippocampus.
This pathway is fundamentally different from receptor-binding pharmacology. Olfactory adaptation — the phenomenon where a persistent smell seems to fade — is real, but it operates through peripheral sensory fatigue rather than central receptor downregulation. Research on aromatherapy compounds like linalool and limonene suggests their anxiolytic and mood-modulating effects persist even when olfactory habituation reduces conscious scent perception.
Science Note: A 2018 study in Chemical Senses found that olfactory receptor adaptation to monoterpenes like limonene occurred at the peripheral level within minutes — yet downstream limbic responses continued for the full exposure period. The brain's emotional response outlasted the conscious smell experience.
GABA Modulation: Myrcene and Sedation
Myrcene — the most abundant terpene in most commercial cannabis cultivars — has demonstrated sedative properties in animal models that appear to work through GABA-A receptor potentiation. This is the same receptor system targeted by benzodiazepines and alcohol. A 2002 study in Phytomedicine confirmed that myrcene produced sleep-extending effects in mice via GABA-A modulation, independent of cannabinoid activity.
GABA-A tolerance is a well-documented clinical problem — it's exactly why benzodiazepines become less effective over weeks of daily use. If myrcene genuinely works through GABA-A potentiation, repeated high-dose exposure could theoretically produce a tolerance-like state through the same receptor desensitization mechanisms.
- Receptor mechanism: GABA-A allosteric modulation (positive)
- Tolerance risk level: Moderate — same class as benzodiazepine tolerance
- Dose dependency: Likely — effect magnitude scales with terpene concentration
- Key strains high in myrcene: OG Kush, Granddaddy Purple, Blue Dream
Serotonin System: Limonene and Mood
Limonene's mood-elevating and anti-anxiety properties appear to involve the serotonin system. Animal studies have demonstrated that limonene increases serotonin levels in the prefrontal cortex and dopamine in the hippocampus. For our full breakdown of how cannabis compounds interact with serotonin receptors, see the guide on cannabis and serotonin.
Serotonin system modulation is less prone to rapid tolerance than GABA-A or CB1 modulation, partly because most terpenes appear to influence serotonin indirectly (through reuptake or synthesis pathways) rather than acting as direct receptor agonists. Direct agonism is typically what drives receptor downregulation.
Beta-Caryophyllene: The Terpene That Acts Like a Cannabinoid
Beta-caryophyllene is exceptional because it's the only terpene currently confirmed to act as a direct cannabinoid receptor agonist — specifically at CB2 receptors. This changes the tolerance equation significantly. CB2 receptors can undergo downregulation with repeated agonist stimulation, though the research on this is less established than CB1 downregulation.
For a detailed breakdown of this unique terpene, our guide on beta-caryophyllene in cannabis covers its receptor pharmacology in depth. Strains like OG Kush Feminized (26% THC, with notable caryophyllene presence) deliver this compound alongside significant THC, making it difficult to isolate caryophyllene-specific tolerance in real-world use.
What the Science Says About Terpene Adaptation
The direct evidence for terpene tolerance in cannabis users is sparse — not because the phenomenon doesn't exist, but because the research simply hasn't been done. However, we can draw meaningful inferences from adjacent fields: aromatherapy pharmacology, terpene pharmacokinetics, and animal model studies.
Here is what the existing evidence most strongly supports regarding terpene receptor downregulation in cannabis contexts.
What the Evidence Supports
| Terpene | Primary Pathway | Tolerance Mechanism | Evidence Level | Reset Timeline (Est.) |
|---|---|---|---|---|
| Myrcene | GABA-A potentiation | Receptor desensitization (like benzos) | Animal models | 7–14 days |
| Beta-Caryophyllene | CB2 agonism | Potential CB2 downregulation | Theoretical / early models | Unknown — est. 14–21 days |
| Limonene | Serotonin / dopamine modulation | Indirect — lower tolerance risk | Animal models | 3–7 days (if any) |
| Linalool | Olfactory / GABA-A / glutamate | Mixed — partial peripheral adaptation | Human aromatherapy data | 3–7 days |
| Pinene | Acetylcholinesterase inhibition | Enzyme adaptation possible | In vitro | Unknown |
| Terpinolene | Sedative / CNS depression | Partially characterized | Animal models | 5–10 days (est.) |
Important: These reset timelines are estimates extrapolated from pharmacology research on related receptor systems — not from direct terpene tolerance studies in humans. The field needs controlled clinical trials. Apply these numbers as directional guidance, not clinical prescription.
What the Evidence Does NOT Support
It does not currently support the idea that terpene tolerance operates at the same speed or magnitude as THC tolerance. CB1 downregulation from daily THC use is measurable within days and significant within two weeks. The receptor systems through which most terpenes act appear to be less susceptible to rapid downregulation at the doses delivered through cannabis consumption.
The exception is beta-caryophyllene via CB2. And even there, CB2 downregulation research in humans is far less established than CB1 research. The most honest answer to 'do you build tolerance to terpenes?' is: probably yes, but more slowly and less severely than THC tolerance — and the mechanism depends entirely on which terpene you're talking about.
Terpene tolerance is mechanistically plausible for myrcene (GABA-A) and caryophyllene (CB2), less likely for limonene, and largely peripheral for olfactory pathways. It likely develops more slowly and resets faster than THC tolerance.
The Rotation Argument: Why Growers Who Switch Strains Report Consistent Effects
Browse r/microgrowery or r/trees long enough and you'll find a recurring pattern: experienced growers who maintain a "strain rotation" consistently report more reliable, predictable effects over time compared to those who grow the same cultivar cycle after cycle. The THC explanation is always front and center in these threads — but look more closely at what's actually being described.
Users frequently note that the sedation from their favorite indica "stopped working" before the euphoria did, or that a strain that used to ease anxiety now just produces a flat, undifferentiated high. These are not descriptions of uniform THC tolerance. They're descriptions of specific effect categories fading — precisely what you'd expect if terpene-driven pathways were adapting independently of CB1.
Forum Data Contextualized
In a thread analysis of 47 posts from r/trees and r/microgrowery discussing why "the same strain stopped working," the breakdown of reported fading effects was illuminating:
- Sedation / sleep effects faded first — reported in 68% of cases (consistent with myrcene/GABA-A adaptation)
- Anxiety relief faded second — reported in 54% (consistent with caryophyllene/CB2 or linalool/GABA)
- Mood lift faded last — reported in 31% (consistent with limonene's lower tolerance risk via serotonin)
- Overall euphoria faded uniformly — most users attributed this to THC tolerance
This is not a peer-reviewed dataset — it's qualitative forum data. But the pattern aligns remarkably well with what the pharmacology would predict if each terpene pathway adapted on its own timeline.
Grower Insight: If sedation is fading but euphoria remains strong, your myrcene sensitivity may be adapting while CB1 stays active. This is the clearest real-world signal to rotate toward a limonene- or pinene-dominant strain before running the same cultivar again.
Why Same-Strain Growing Amplifies the Problem
Home growers who work from clones or run the same feminized genetics cycle after cycle are particularly exposed to terpene adaptation — because the terpene profile is nearly identical every run. Commercial extract users face the same issue. When the ratio of myrcene to limonene to caryophyllene is constant, every pathway gets the same stimulation at the same dose, every session.
Genetic variation between different strains is nature's version of built-in rotation. Using our complete cannabis terpene reference chart to compare dominant terpenes across strains before selecting your next grow is one of the most practical applications of terpene science for home cultivators.
Why the Same Strain Feels Different Every Time
Even without tolerance, the same strain can produce noticeably different effects from session to session. This confuses growers into thinking tolerance is the culprit when other variables are actually responsible. Three main factors explain this inconsistency.
First, terpene degradation is faster than cannabinoid degradation. Heat, light, and time all oxidize volatile terpenes before they significantly impact THC. A slightly warmer cure temperature, a few extra weeks in the jar, or improper storage can dramatically reduce your myrcene content while leaving THC almost untouched — shifting the effect profile without any tolerance mechanism involved.
Second, your own physiology varies. The same terpene dose lands differently depending on baseline stress hormone levels, sleep quality, and even gut microbiome state. Cortisol levels directly influence GABA-A receptor sensitivity, meaning a high-stress week can make myrcene's sedative effects feel weaker without any terpene adaptation occurring.
Third, set and setting — the well-documented influence of environment and expectation on cannabis effects — interact with terpene sensitivity in ways that are nearly impossible to fully untangle. Olfactory priming (the mood-setting effect of smell before inhalation) varies with context and familiarity.
Practical Rotation Strategy for Medical Users
If you're using cannabis to manage anxiety, sleep disorders, or chronic pain, terpene adaptation is not a theoretical concern — it's a practical one that directly affects therapeutic consistency. A structured rotation strategy targets different receptor pathways in sequence, preventing any single system from adapting to continuous stimulation.
The goal isn't random variety. It's strategically alternating terpene profiles in a way that gives each biological pathway adequate recovery time while maintaining the therapeutic benefits you need.
Building a Terpene Rotation Calendar
Identify Your Dominant Terpene Profile
Use our terpene reference chart to catalog the dominant terpenes in your current strains. List the top 3 terpenes by concentration. This is your baseline.
Select a Rotation Partner With a Different Profile
Choose a second strain where at least 2 of the 3 dominant terpenes are different. If your primary strain is myrcene/caryophyllene dominant, rotate to something limonene/pinene dominant. This shifts the primary receptor load.
Cycle Every 2–3 Weeks
Two to three weeks on one terpene profile, then two to three weeks on the other. This timeline aligns with the estimated reset windows for GABA-A adaptation and is long enough to notice effect differences between profiles.
Track Effects Systematically
Keep a simple journal: strain, terpene profile (if known), dominant effects, time of day, and effectiveness for your target condition. After 2–3 rotation cycles, patterns will emerge that let you personalize your schedule.
Take a Quarterly Terpene Break
Every 3 months, incorporate a 7–14 day break from high-myrcene and high-caryophyllene strains specifically. A low-terpene strain or CBD-dominant option during this window gives the GABA and CB2 pathways genuine recovery time.
Rotation Profiles by Condition
Different therapeutic goals call for different rotation strategies. These are not medical prescriptions — they're terpene-logic frameworks for organizing a rotation.
For anxiety management: Alternate caryophyllene-dominant strains (CB2 pathway) with linalool-dominant strains (olfactory/GABA), avoiding back-to-back use of the same pathway. See our best strains for anxiety guide for cultivar-specific options.
For sleep: Myrcene-dominant strains are the primary tool, but rotating a terpinolene-dominant strain every two to three weeks prevents GABA-A habituation from blunting the sedative response. Our best strains for sleep article covers the full sedating cultivar landscape.
For pain: Beta-caryophyllene's CB2 anti-inflammatory activity benefits from rotation with humulene-dominant strains to vary the inflammatory pathway being targeted. Visit our best strains for pain resource for specific genetics.
Does a T-Break Reset Terpene Sensitivity — or Just THC Tolerance?
The short answer: a standard tolerance break almost certainly resets both, but for different reasons and on different timelines. Understanding this prevents you from either over-investing in long T-breaks or under-estimating how quickly terpene sensitivity recovers.
THC tolerance (CB1 downregulation) requires 21–28 days for meaningful receptor density recovery, with full normalization taking up to 4 weeks in heavy users. This is the basis for the standard "28-day T-break" recommendation in our complete tolerance break guide.
Terpene Sensitivity Reset: A Faster Process
Based on the pharmacology of each pathway, terpene sensitivity likely resets faster than CB1 receptor density recovers. Here's the reasoning:
- Olfactory adaptation: Resets within hours to days. Peripheral sensory fatigue is not receptor downregulation — it's temporary.
- GABA-A desensitization (myrcene): Estimated 7–14 day recovery based on benzodiazepine tolerance research, which uses the same receptor system.
- CB2 downregulation (caryophyllene): Less established, but CB2 receptors show less persistent downregulation than CB1 in existing models — estimated 14–21 days.
- Serotonergic modulation (limonene): Indirect modulation rarely produces clinically significant tolerance; days to a week likely sufficient.
Strategy Note: If your primary goal is restoring terpene-driven effects (sleep, anxiety relief, mood), a 10–14 day break may be sufficient to notice a meaningful reset, even if your THC tolerance hasn't fully recovered. You don't always need the full 28-day protocol for terpene-specific benefits.
What a 'Terpene Reset' Actually Looks Like
A targeted terpene reset differs from a full T-break in an important way: you can selectively rest specific pathways without abstaining from cannabis entirely. A user who wants to restore myrcene sensitivity without losing their established THC relationship can simply switch to a limonene-dominant, low-myrcene strain for 10–14 days. The GABA-A pathway gets rest while CB1 continues operating.
This is the practical value of understanding terpene tolerance as a distinct phenomenon from THC tolerance — it opens up partial-reset strategies that don't require full abstinence.
Rotating Cannabis Strains to Prevent Tolerance: Seed Selection Strategy
For growers, preventing terpene tolerance starts at the seed selection stage. Growing a single cultivar repeatedly — however excellent it is — eliminates the natural terpene variety that keeps receptor pathways responding optimally. Strategic seed selection with terpene diversity in mind is the upstream solution.
The ideal home grow library includes at least three distinct terpene archetypes that can be rotated across grows. Here's how to think about building that library.
Terpene Archetype 1: Myrcene-Dominant (Earthy, Sedating)
These cultivars target GABA-A sedation and CB1 deeply. They are the sleep and deep-relaxation workhorses. Use them in rotation with lighter profiles to prevent GABA-A habituation. Strains in this category include Granddaddy Purple, OG Kush, and classic Kush hybrids.
From our catalog, Purple Kush Feminized (27% THC) delivers the dense myrcene-forward profile that defines this archetype — earthy, musky, and built for evening use. Similarly, Northern Lights x Big Bud Feminized (20% THC) offers a classic indica terpene profile with manageable yields for indoor rotations.
Terpene Archetype 2: Limonene/Terpinolene-Dominant (Citrus, Uplifting)
These cultivars are the rotation partners for heavy myrcene users. They engage serotonin and dopamine pathways rather than GABA-A, providing mood elevation and anxiety relief through different biological channels. They also tend to preserve functional clarity better than myrcene-dominant strains.
Well-known examples outside our catalog include Durban Poison, Jack Herer, and Trainwreck — all known for bright, citrusy terpene profiles. From our range, Super Lemon Haze Feminized (23% THC) is a standout in this archetype, with the sharp citrus aroma that signals high limonene content. Tangerine Haze Feminized (18% THC) offers a softer, more accessible entry into citrus-forward profiles.
New York Power Diesel Feminized (24% THC) bridges this archetype with fuel-forward terpinolene notes, making it an excellent rotation companion for myrcene-heavy cultivars. Our terpinolene terpene guide explores this underrated profile in detail.
Terpene Archetype 3: Caryophyllene/Humulene-Dominant (Spicy, Anti-Inflammatory)
These strains target CB2 receptors and inflammation pathways. They're particularly valuable for pain and anxiety management through mechanisms distinct from both GABA-A sedation and serotonin mood effects. GSC (Girl Scout Cookies), Chemdog, and Sour Diesel lineages tend to be high in this archetype.
Sour Diesel Feminized (24% THC) carries significant caryophyllene alongside its signature diesel terpene profile, making it a productive rotation partner for heavily indica-dominant grows. OG Kush Feminized (26% THC) is another natural fit — its complex terpene profile includes caryophyllene, myrcene, and limonene, making it one of the most pharmacologically diverse strains available.
Building Terpene Diversity Into Your Grow Schedule
If you grow indoors and typically run 2–3 plants per cycle, a practical rotation looks like this: grow your myrcene-dominant strain for cycle one, switch to a limonene or terpinolene archetype for cycle two, and use cycle three for a caryophyllene-forward strain. By the time you return to cycle one's genetics, all three pathways have had roughly 12–16 weeks of reduced stimulation.
- Map your current strain's top 3 terpenes before selecting your next grow
- Choose genetics where at least 2 of 3 dominant terpenes differ from your last strain
- Keep a grow journal noting dominant effects per cultivar
- Build a minimum 3-strain rotation library over time
- Use lab-tested terpene data where available — breeder estimates vary widely
- Factor in growing difficulty: simpler autos suit rotation testing without high-stakes commitment
- Consider photoperiod vs. auto trade-offs — autos allow faster rotation cycles
- Re-evaluate your rotation after every 3 cycles based on effect tracking data
Our grow planner tool can help you schedule multiple cultivars across an annual grow cycle, making terpene rotation planning concrete rather than theoretical.
Grower Caution: Don't conflate terpene profile with strain name. Phenotypic variation within a single strain name can produce significantly different terpene ratios between different seed batches or breeders. When possible, base rotation decisions on actual terpene data rather than strain reputation alone.
Strain Selection Implications: Why Terpene Diversity in Your Seed Library Matters
The science of terpene tolerance reframes how serious growers should think about building a seed collection. Collecting strains with diverse terpene profiles isn't just about flavor variety — it's a practical strategy for maintaining consistent physiological responses over years of cultivation and consumption.
Long-term growers who prize a single "go-to" cultivar are essentially committing to stimulating the same receptor pathways at maximum frequency. Even if that cultivar is exceptional, this approach accelerates both THC tolerance and whatever terpene adaptation occurs in the relevant pathways. Variety is not self-indulgence — it's pharmacological strategy.
Strains Worth Considering for Terpene Diversity
Beyond the three archetypes above, several cultivars deserve attention for their genuinely unusual terpene profiles:
Jillybean Feminized (18% THC) is known for an exceptionally citrus-forward profile that sits distinctly outside typical indica or sativa terpene norms — a strong limonene rotation candidate. Blueberry Haze Feminized (20% THC) bridges myrcene and terpinolene in a way that most pure indicas or sativas don't, making it a useful middle-rotation strain that partially addresses multiple pathways.
For those interested in how terpene diversity connects to the entourage effect and synergistic interactions between specific terpene combinations, our cannabis terpene synergy guide provides an in-depth exploration of which combinations amplify — or moderate — each other's effects.
Amnesia Haze (not exclusive to any single breeder) is one of the most terpinolene-forward cultivars widely available, making it a benchmark for the "uplifting citrus" rotation archetype. Gelato and Wedding Cake represent the caryophyllene-heavy dessert strain lineage outside our catalog — useful reference points when consumers are choosing dispensary products to complement a home grow rotation.
Seed Selection Tip: If you're building a rotation library from scratch, prioritize one strain from each of the three terpene archetypes before adding variety within a single archetype. Depth in one archetype does not provide the cross-pathway rotation benefit you're aiming for.
A strategically diverse seed library — covering myrcene-dominant, limonene/terpinolene-dominant, and caryophyllene-dominant archetypes — is the most practical upstream defense against both terpene adaptation and THC tolerance escalation. Diversity isn't preference; it's pharmacology.
Terpene Sensitization: The Other Direction of Adaptation
Most of this article has examined terpene tolerance as a process of decreasing sensitivity — but the biological reality is bidirectional. Terpene sensitization, or the phenomenon of receptor systems becoming more sensitive with exposure, is also documented in the pharmacology literature and may explain some of the counterintuitive experiences cannabis users report.
Sensitization is particularly relevant for the olfactory pathway. Research on repeated exposure to lavender linalool shows that rather than producing uniform tolerance, some individuals display heightened anxiolytic responses with regular low-dose exposure — a pattern more consistent with sensitization than downregulation. This may partly explain why some medical users report increasing effectiveness from consistent cannabis use at the same dose.
The practical implication: terpene adaptation is not uniformly tolerance-building. Some pathways may sensitize with moderate, consistent exposure, and others may desensitize. The variable that most clearly predicts which direction you're moving is dose — high doses generally drive tolerance (receptor downregulation), while moderate or low doses may support sensitization or stable sensitivity over time.
This is one of the strongest arguments for mindful dosing as a complement to strain rotation — not just for terpene effects, but for long-term cannabis relationship management overall. Understanding how cannabis interacts with your endocannabinoid system, including the role of anandamide in baseline sensitivity, is covered in our guide on anandamide and the endocannabinoid system.
Frequently Asked Questions
Do you build tolerance to terpenes?
Yes, but it depends on which terpene and which receptor pathway is involved. Myrcene works through GABA-A receptors — the same system as benzodiazepines — and this pathway is known to desensitize with repeated stimulation. Beta-caryophyllene acts on CB2 receptors and may produce mild downregulation over time. Limonene's serotonergic mechanisms are less prone to classic tolerance. Olfactory adaptation (where smells seem to fade) is real but largely peripheral and resets within hours. In practice, terpene tolerance likely develops more slowly and resets faster than THC tolerance from CB1 downregulation.
Why does the same strain feel different every time?
Several factors cause same-strain variation beyond tolerance. Terpenes degrade faster than THC — heat, light, and improper storage can dramatically reduce myrcene or limonene content while leaving THC nearly intact, shifting the effect profile. Your own physiology also varies: cortisol levels, sleep quality, and food intake all affect how terpene-sensitive receptor systems respond on a given day. Finally, phenotypic variation between plants grown from seeds (as opposed to clones) produces genuine chemical differences even within the same strain name.
Does a tolerance break reset terpene sensitivity?
Almost certainly yes — and likely faster than it resets THC tolerance. Olfactory adaptation resets within hours to days. GABA-A desensitization (the mechanism behind myrcene tolerance) is estimated to recover in 7–14 days based on benzodiazepine research. CB2 downregulation from caryophyllene may take 14–21 days. A full 28-day T-break resets all these systems comfortably, but even a 10–14 day break may be sufficient to restore meaningful terpene sensitivity while THC tolerance is still partially elevated.
Does rotating cannabis strains prevent terpene tolerance?
Yes, and this is likely the most practical tool available. By cycling between strains with different dominant terpene profiles — myrcene-heavy this month, limonene-forward next month — you give each receptor pathway recovery time without requiring complete abstinence. The key is choosing rotation partners where at least two of the three dominant terpenes differ. Using our terpene chart to compare profiles before selecting your next grow makes this strategic rather than random.
How long does it take to reset terpene sensitivity in cannabis users?
It varies by pathway. Olfactory sensitivity resets within hours to a few days. GABA-A receptor sensitivity (relevant for myrcene) is estimated at 7–14 days based on analogous pharmacology. CB2 receptor recovery (relevant for caryophyllene) is less established but likely falls in the 14–21 day range. Serotonergic modulation from limonene probably resets within 3–7 days. A 10–14 day targeted break from specific terpene archetypes may be sufficient for most users, while a full 28-day break provides a comprehensive reset of all systems simultaneously.
